tert-Butyl 3-hydroxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate

Catalog No. :
ACGPNE670
CAS No. :
625098-86-4
Molecular Formula :
C13H18N2O3
Molecular Weight :
250.30

IUPAC Name:tert-butyl 3-hydroxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate

tert-Butyl 3-hydroxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$807.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-hydroxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate
IUPAC Nametert-butyl 3-hydroxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate
MDL No.MFCD10698626
Molecular FormulaC13H18N2O3
Molecular Weight250.30
SMILESO=C(N1CC2=C(N=CC(O)=C2)CC1)OC(C)(C)C
InChI KeyKGHGKHAUTOHDTA-UHFFFAOYSA-N
Synonym6-Boc-3-hydroxy-7,8-dihydro-5H-1,6phthyridine;tert-butyl 3-hydroxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate;tert-butyl 3-hydroxy-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate;1,6-Naphthyridine-6(5H)-carboxylic acid, 7,8-dihydro-3-hydroxy-, 1,1-dimethylethyl ester
CAS No.625098-86-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGPNE670 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGPNE670 route product structure diagram
    ACGPNE670625098-86-4
Inquiry

2. ACGPNE670 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTFSH962 route compound structure diagram
    ACTFSH962625098-88-6 In Stock
  4. Then
  5. ACGPNE670 route product structure diagram
    ACGPNE670625098-86-4
Inquiry

Comments (0)